UK markets closed

Zepp Health Corporation (ZEPP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
0.8530+0.0130 (+1.55%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 51.16M
Enterprise value 107.01M
Trailing P/E 5.13
Forward P/E 3.12
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.15
Price/book (mrq)0.15
Enterprise value/revenue 0.04
Enterprise value/EBITDA -0.79

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3-40.76%
S&P500 52-week change 322.36%
52-week high 32.1000
52-week low 30.8200
50-day moving average 31.0492
200-day moving average 31.2112

Share statistics

Avg vol (3-month) 369.58k
Avg vol (10-day) 355.67k
Shares outstanding 559.98M
Implied shares outstanding 661.04M
Float 898.73M
% held by insiders 13.47%
% held by institutions 130.48%
Shares short (15 Apr 2024) 423.25k
Short ratio (15 Apr 2024) 40.26
Short % of float (15 Apr 2024) 40.05%
Short % of shares outstanding (15 Apr 2024) 40.04%
Shares short (prior month 15 Mar 2024) 42.23k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 315 Apr 2022
Ex-dividend date 425 Mar 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -8.50%
Operating margin (ttm)0.89%

Management effectiveness

Return on assets (ttm)-2.65%
Return on equity (ttm)-8.19%

Income statement

Revenue (ttm)2.5B
Revenue per share (ttm)41.05
Quarterly revenue growth (yoy)-44.00%
Gross profit (ttm)N/A
EBITDA -152.65M
Net income avi to common (ttm)-212.12M
Diluted EPS (ttm)-0.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)985.62M
Total cash per share (mrq)4.11
Total debt (mrq)914.33M
Total debt/equity (mrq)36.51%
Current ratio (mrq)2.04
Book value per share (mrq)41.40

Cash flow statement

Operating cash flow (ttm)298.67M
Levered free cash flow (ttm)664.88M